Artemis Real Estate Partners, headquartered in Washington, DC, is a diversified real estate firm with investment expertise across the risk spectrum. The firm has consistently delivered strong ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Barings, one of the world’s leading investment managers, announced today that it has entered into a definitive agreement to acquire Artemis Real Estate Partners ...

Barings, one of the world’s leading investment managers, announced today that it has entered into a definitive agreement to acquire Artemis Real Estate Partners (“Artemis”), an $11+ billion ...

This summary is reviewed by TRD Staff. Barings is acquiring Artemis Real Estate Partners, significantly increasing its real estate assets under management to over $60 billion. Artemis, a female ...

Artemis Real Estate Partners has bought Berkeley Central, located at 2055 Center St., from Los Angeles-based developer CityView for $55 million, records on file with the Alameda County Assessor ...

“Artemis’ track record and best-in-class value-add skill set was a significant driver in the transaction,” Barings Head of U.S. and European Real Estate John Ockerbloom told PERE.

CHARLOTTE, N.C., February 18, 2025--(BUSINESS WIRE)--Barings, one of the world’s leading investment managers, announced today that it has entered into a definitive agreement to acquire Artemis Real ...

When astronauts walk on the moon, they'll serve as the eyes, hands, and boots-on-the-ground interpreters supporting the ...

The Defense Innovation Unit (DIU) announced that four companies were awarded contracts for Artemis, a project to ...

Barings entered into a definitive agreement to acquire Artemis Real Estate Partners, a women-founded a real estate investment firm with more than $11 billion in assets under management.

This story is part of your SHN+ subscription Two major real estate acquisitions announced in the last two weeks are setting a faster pace for senior ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...